170 related articles for article (PubMed ID: 37480398)
1. Denosumab improves bone mineral density and microarchitecture in rheumatoid arthritis: randomized controlled trial by HR-pQCT.
Chiba K; Iwamoto N; Watanabe K; Shiraishi K; Saito K; Okubo N; Kawakami A; Osaki M
J Bone Miner Metab; 2023 Nov; 41(6):797-806. PubMed ID: 37480398
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study.
Iwamoto N; Chiba K; Sato S; Shiraishi K; Watanabe K; Oki N; Okada A; Koga T; Kawashiri SY; Tamai M; Hosogaya N; Furuyama M; Kobayashi M; Saito K; Okubo N; Uetani M; Osaki M; Kawakami A
Arthritis Res Ther; 2022 Dec; 24(1):264. PubMed ID: 36476479
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT.
Iwamoto N; Sato S; Sumiyoshi R; Chiba K; Miyamoto N; Arinaga K; Kobayashi M; Yamamoto H; Osaki M; Kawakami A
Trials; 2019 Aug; 20(1):494. PubMed ID: 31409388
[TBL] [Abstract][Full Text] [Related]
4. Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.
Nakamura Y; Suzuki T; Kato H
Arch Osteoporos; 2017 Sep; 12(1):80. PubMed ID: 28936606
[TBL] [Abstract][Full Text] [Related]
5. Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
Agarwal S; Shiau S; Kamanda-Kosseh M; Bucovsky M; Kil N; Lappe JM; Stubby J; Recker RR; Guo XE; Shane E; Cohen A
J Bone Miner Res; 2023 Jan; 38(1):35-47. PubMed ID: 36335582
[TBL] [Abstract][Full Text] [Related]
6. Compartment-specific effects of muscle strength on bone microarchitecture in women at high risk of osteoporosis.
Simon A; Schäfer HS; Schmidt FN; Stürznickel J; Amling M; Rolvien T
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2310-2321. PubMed ID: 35852049
[TBL] [Abstract][Full Text] [Related]
7. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.
Takeuchi T; Tanaka Y; Soen S; Yamanaka H; Yoneda T; Tanaka S; Nitta T; Okubo N; Genant HK; van der Heijde D
Ann Rheum Dis; 2019 Jul; 78(7):899-907. PubMed ID: 31036625
[TBL] [Abstract][Full Text] [Related]
8. Bone density and microarchitecture: relationship between hand, peripheral, and axial skeletal sites assessed by HR-pQCT and DXA in rheumatoid arthritis.
Zhu TY; Griffith JF; Qin L; Hung VW; Fong TN; Kwok AW; Leung PC; Li EK; Tam LS
Calcif Tissue Int; 2012 Nov; 91(5):343-55. PubMed ID: 22945690
[TBL] [Abstract][Full Text] [Related]
9. Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: possible beneficial effect of leflunomide.
Kwon OC; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
Clin Exp Rheumatol; 2019; 37(5):813-819. PubMed ID: 30767868
[TBL] [Abstract][Full Text] [Related]
10. Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy.
Hopson MB; Onishi M; Awad D; Buono D; Maurer M; Crew KD; Shane E; Hershman DL; Kalinsky K
Clin Breast Cancer; 2020 Jun; 20(3):e327-e333. PubMed ID: 31926840
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
Böttcher J; Pfeil A; Lehmann G; Heinrich B; Malich A; Hansch A; Petrovitch A; Mentzel HJ; Hein G; Kaiser WA
Z Rheumatol; 2004 Dec; 63(6):473-82. PubMed ID: 15605213
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.
Ramchand SK; David NL; Lee H; Bruce M; Bouxsein ML; Tsai JN; Leder BZ
J Bone Miner Res; 2023 Jan; 38(1):26-34. PubMed ID: 36333954
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
Matsuno H
Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
[TBL] [Abstract][Full Text] [Related]
14. Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study.
Chen MH; Yu SF; Chen JF; Chen WS; Liou TL; Chou CT; Hsu CY; Lai HM; Chen YC; Tsai CY; Cheng TT
Front Immunol; 2021; 12():783030. PubMed ID: 34987510
[TBL] [Abstract][Full Text] [Related]
15. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
16. Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
Ramchand SK; David NL; Lee H; Bruce M; Bouxsein ML; Leder BZ; Tsai JN
J Bone Miner Res; 2021 Jan; 36(1):41-51. PubMed ID: 32790196
[TBL] [Abstract][Full Text] [Related]
17. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
Juhász B; Gulyás K; Horváth Á; Pethő Z; Bhattoa HP; Váncsa A; Szekanecz É; Horváth C; Kocsis J; Horváth Z; Hodosi K; Szántó S; Szűcs G; Szekanecz Z
Osteoporos Int; 2017 Apr; 28(4):1271-1277. PubMed ID: 27942777
[TBL] [Abstract][Full Text] [Related]
18. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.
Samelson EJ; Broe KE; Xu H; Yang L; Boyd S; Biver E; Szulc P; Adachi J; Amin S; Atkinson E; Berger C; Burt L; Chapurlat R; Chevalley T; Ferrari S; Goltzman D; Hanley DA; Hannan MT; Khosla S; Liu CT; Lorentzon M; Mellstrom D; Merle B; Nethander M; Rizzoli R; Sornay-Rendu E; Van Rietbergen B; Sundh D; Wong AKO; Ohlsson C; Demissie S; Kiel DP; Bouxsein ML
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):34-43. PubMed ID: 30503163
[TBL] [Abstract][Full Text] [Related]
19. Denosumab increases spine bone density in women with anorexia nervosa: a randomized clinical trial.
Haines MS; Kimball A; Meenaghan E; Santoso K; Colling C; Singhal V; Ebrahimi S; Gleysteen S; Schneider M; Ciotti L; Belfer P; Eddy KT; Misra M; Miller KK
Eur J Endocrinol; 2022 Nov; 187(5):697-708. PubMed ID: 36134902
[TBL] [Abstract][Full Text] [Related]
20. Age-related reference data of bone microarchitecture, volumetric bone density, and bone strength parameters in a population of healthy Brazilian men: an HR-pQCT study.
Alvarenga JC; Caparbo VF; Domiciano DS; Pereira RMR
Osteoporos Int; 2022 Jun; 33(6):1309-1321. PubMed ID: 35059775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
